Showing results (341-350 of 34,172) with videos related to
Sort By:
Pageof 3,418
International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care|July 5, 2015
Examining the attitudes of hospital pharmacists to reporting medication safety incidents using the theory of planned behaviourSteven David Williams, Denham L Phipps, Darren AshcroftNeurosurgery|December 1, 1985
Uptake and retention of hematoporphyrin derivative in an in vivo/in vitro model of cerebral gliomaA H Kaye, G Morstyn, R G AshcroftCell Stem Cell|March 5, 2021
Myeloproliferative Neoplasms: The Long Wait for JAK2-Mutant Clone ExpansionDamien Luque Paz, Peter Ashcroft, Radek C SkodaJournal of the American Chemical Society|April 29, 2011
Benzene under high pressure: a story of molecular crystals transforming to saturated networks, with a possible intermediate metallic phaseXiao-Dong Wen, Roald Hoffmann, N W AshcroftPflugers Archiv : European Journal of Physiology|June 1, 1990
Tolbutamide reverses membrane hyperpolarisation induced by activation of D2 receptors and GABAB receptors in isolated substantia nigra neuronesJ Roeper, A H Hainsworth, F M AshcroftThe Annals of Pharmacotherapy|June 23, 2011
Prevalence of adverse drug events in ambulatory care: a systematic reviewStephanie V Taché, Andreas Sönnichsen, Darren M AshcroftDiabetologia|February 1, 1986
Effect of adrenal steroids on insulin release from cultured rat islets of LangerhansJ Pierluissi, F O Navas, S J AshcroftMolecular and Cellular Biology|February 18, 1999
Regulation of p53 function and stability by phosphorylationM Ashcroft, M H Kubbutat, K H VousdenDiabetes|October 29, 1998
Sulfonylureas enhance exocytosis from pancreatic beta-cells by a mechanism that does not involve direct activation of protein kinase CY A Tian, G Johnson, S J AshcroftAntioxidants & Redox Signaling|September 10, 2009
Prolyl hydroxylase domain inhibitors: a route to HIF activation and neuroprotectionSarah K Harten, Margaret Ashcroft, Patrick H MaxwellPageof 3,418